SightGlass Vision’s Joe Rappon details the “simple and achievable” idea that will revolutionize how to treat/prevent myopia, along with details on CYPRESS, the pivotal p3 study (results in Q2 2020).
Joe Rappon, MD, Chief Medical Officer – Sightglass Vision during the Innovative Showcase at OIS@AAO 2019.
REGISTER for our next ophthalmology conference today.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.